Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countries.
Despite the high burden of hyperlipidemia and the effectiveness of treatment, evidence suggests that the accessibility of hyperlipidemia medicines can be low in many low- and middle-income countries (LMICs). The aim of this study was to identify common barriers to the accessibility of medicines for...
Spremljeno u:
| Glavni autori: | , , , , , , |
|---|---|
| Format: | Knjiga |
| Izdano: |
Public Library of Science (PLoS),
2024-01-01T00:00:00Z.
|
| Teme: | |
| Online pristup: | Connect to this object online. |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Internet
Connect to this object online.3rd Floor Main Library
| Signatura: |
A1234.567 |
|---|---|
| Primjerak 1 | Dostupno |